Summary
Generation Bio Co
Founded in 2016
Description
Generation Bio is a biotechnology company that is pushing the limits of genetic medicine. They are focused on providing durable, redosable treatments for people living with rare and prevalent diseases. Their non-viral platform incorporates a novel DNA ...
Strengths
- Generation Bio Co has a strong market share in their industry
- Revenue generated per employee is greater than industry average
- Demonstrating revenue growth that is faster than the industry average
- The number of employees is growing faster than the industry average
- Revenue growth is more steady than the industry average
- Since Generation Bio Co was founded, the company has grown faster than the industry average
- Employees are staying with the company and less likely to churn compared to the rest of the industry
Weaknesses
- Web traffic rankings are worse than the industry average
Annual Revenue
Generation Bio Co's annual revenue
$50636000
Based on Kona Equity data
-
Revenue per employee
$337573
-
Variance of revenue growth
0.04
-
Annual revenue growth since founding
$6329500
-
Revenue growth rate from first known quarter to current
180.6%
Employee Count
150 employees
-
Employee growth rate from first known quarter to current
221.2%
-
Current employees on Linkedin
99
-
Churned employees
28
-
Churn rate percentage
28.28%
Executives
William Mccarthy
Chief Business Officer
w**@generationbio.comPhillip Samayoa
Chief Strategy Officer
p**@generationbio.comJennifer Elliott
Chief Legal Officer
j**@generationbio.comBryant Marina
People Operations Benefits Analyst
b**@generationbio.comJessica Keenan
Scientist
j**@generationbio.comDouglas Kerr
Chief Medical Officer
d**@generationbio.comAntoinette Paone
Chief Operating Officer
a**@generationbio.comLauren Ferreira
Research Assistant
l**@generationbio.comJasmin Tower
Senior VP, People & Operations
j**@generationbio.comJennifer Dittman
Vice President, Regulatory Affairs & Medical Writing
j**@generationbio.comTracy Zimmermann
Chief Development Officer
t**@generationbio.comGeoffrey Mcdonough
CEO
g**@generationbio.comMatthew Stanton
Chief Scientific Officer
m**@generationbio.comRenee Gramolini
People Operations Senior Analyst
r**@generationbio.comJicong Cao
Principal Scientist
j**@generationbio.comAdebayo Lawal
Vice President, Clinical Development
a**@generationbio.comBarbara Seymour
Senior Director, Manufacturing & Technology
b**@generationbio.comKelly Miller
Senior Scientist
k**@generationbio.comNicholas Hanovice
Scientist, Retinal Biology
n**@generationbio.comMatthew Norkunas
Chief Financial Officer
m**@generationbio.comCharlotte Tausche
Drug Product Formulation Associate Scientist
c**@generationbio.comMatt Chiocco
Senior Director, Preclinical Pharmacology
m**@generationbio.comNidhi Shah
Principal Associate Sci, Downstream Process Development
n**@generationbio.comKevin Conway
Controller
k**@generationbio.comJoyce Pinkham
Head Vice President, Program & Alliance Management
j**@generationbio.comPhone Bio
President & Chief Executive Officer
p**@generationbio.comSonia Razzetti
Vice President, Quality
s**@generationbio.comCurtis Rising
Development Vice President, People
c**@generationbio.comG Score - 7
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G2 Income per employee more than industry average.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G4 Employee growth rate from the first known quarter to current is higher than the industry average.
- G5 Variance of revenue growth is less than the industry average
- G6 Annual revenue growth since founding is higher than the industry average.
- G8 LinkedIn Churn is lower than the industry average.
Web Analysis
-
Rank
3.41 M
-
Page views per visitor
4.0
-
Daily time
6:55
-
Bounce Rate
9.1 %
Location
Unlock unlimited leads
Similar Companies
Adverum Biotechnologies
adverum.com- Founded in 2006
- Location: Redwood City, CA
- Annual Revenue: $7.5M
- Employees: 188
- Adverum Biotechnologies is a clinical stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases. Their mission is to develop functional cures through gene therapy to restore vision and prevent blin...
Sigilon Therapeutics Inc
sigilon.com- Founded in 2015
- Location: Cambridge, MA
- Annual Revenue: $11.4M
- Employees: 66
- Sigilon Therapeutics is a biotechnology company based in Cambridge, MA. They are pioneering Shielded Living Therapeutics, a platform that harnesses the full power of cell therapeutics to address the treatment challenges of serious chronic diseases. Th...
Beam Therapeutics
beamtx.com- Founded in 2017
- Location: Cambridge, MA
- Annual Revenue: $60.9M
- Employees: 507
- Beam Therapeutics is a biotechnology company that is revolutionizing gene-based editing. They are using CRISPR base editing technology to develop a broad portfolio of advanced genetic medicines. Their base editing technology allows for permanent, speci...
Akouos
akouos.com- Founded in 2016
- Location: Boston, MA
- Annual Revenue: $34.8M
- Employees: 103
- Our Mission: Healthy Hearing Available to All. We are a precision genetic medicine company focused on developing gene therapies with the potential to restore, improve and preserve high-acuity physiologic hearing for people worldwide who live with disa...
Vor Biopharma
vorbio.com- Founded in 2015
- Location: Cambridge, MA
- Annual Revenue: $45.6M
- Employees: 135
- Engineered hematopoietic stem cells that unleash the potential of targeted therapies. Hide healthy cells, expose cancer cells.
Editas Medicine Inc
editasmedicine.com- Founded in 2013
- Location: Cambridge, MA
- Annual Revenue: $19.7M
- Employees: 226
- Editas Medicine is a leading gene editing company focused on developing CRISPR medicines for people with serious diseases. They are pioneering the use of CRISPR gene editing to develop a robust pipeline of transformative genomic medicines for various d...
Key Information
- Name: Generation Bio Co
- Category: Biotechnology
- Industry: Biotechnology Company
- SIC: 2834
- NAICS: 32541; 3254
See similar companies
-
By City Cambridge Small Biotechnology Company in Cambridge Mid-size Biotechnology Company in Cambridge Biotechnology in Cambridge Small Biotechnology in Cambridge Mid-size Biotechnology in Cambridge
-
By State MA Small companies in MA Biotechnology in MA Small Biotechnology in MA Mid-size Biotechnology in MA Small Biotechnology Company in MA Mid-size Biotechnology Company in MA
-
By Category Biotechnology Small Biotechnology Mid-size Biotechnology
-
By Industry Biotechnology Company Small Biotechnology Company Mid-size Biotechnology Company Biotechnology and Biotechnology Company
-
Firmographic data G Score of 7 Founded in 2016 SIC: 2834 NAICS: 32541 NAICS: 3254 #Drug Manufacturing & Research #Pharmaceuticals #Healthcare
Frequently Asked Questions
Generation Bio Co's headquarters are located at 301 Binney St. Cambridge, MA 02142.
Generation Bio Co's official website is generationbio.com
Generation Bio Co's annual revenue is $50.6 M.
Generation Bio Co's SIC: 2834
Generation Bio Co's NAICS: 32541; 3254.
Generation Bio Co has 150 employees
Generation Bio Co is in the industry of Biotechnology.
